0000899243-19-006432.txt : 20190306
0000899243-19-006432.hdr.sgml : 20190306
20190306160628
ACCESSION NUMBER: 0000899243-19-006432
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190305
FILED AS OF DATE: 20190306
DATE AS OF CHANGE: 20190306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brennan Aoife
CENTRAL INDEX KEY: 0001714563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 19662577
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET, SUITE 320
STREET 2: C/O SYNLOGIC, INC.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNLOGIC, INC.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-401-9975
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Mirna Therapeutics, Inc.
DATE OF NAME CHANGE: 20110809
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-05
0
0001527599
SYNLOGIC, INC.
SYBX
0001714563
Brennan Aoife
C/O SYNLOGIC, INC.
301 BINNEY STREET, SUITE 402
CAMBRIDGE
MA
02142
1
1
0
0
See Remarks
Stock Option (right to buy)
8.59
2019-03-05
4
A
0
185000
0.00
A
2029-03-05
Common Stock
185000
185000
D
The options vest and become exercisable in substantially equal monthly installments beginning on April 5, 2019 and continuing until March 5, 2023, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.
President, Chief Executive Officer and Chief Medical Officer
/s/ William J. Bussiere, Jr., Attorney-in-fact
2019-03-06